is januvia a glp 1 agonist Recent updates on GLP-1 agonists: Current advancements & challenges Can you take jardiance and

Description

Discover the benefits, mechanisms, and latest applications of GLP-1 receptor agonists in diabetes and obesity treatment.

Some Medicare patients will be able to access GLP-1 medication for weight loss for the first time starting July 1, paying a $50 monthly copay through a new program designed to make the drugs more...

Indication expansion, such as approvals for additional metabolic and cardiovascular conditions, is broadening patient access and driving adoption

At the same time, both Lilly and Novo Nordisk made multi-billion dollar capital investments in expanding their manufacturing capacity to satisfy unrelenting patient demand, including pharmas largest M&A deal of the year, the $16.5Bn acquisition of CDMO Catalent by Novo Holdings, the controlling shareholder of Novo Nordisk